BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Saito T, Watanabe M, Nishida J, Izumi T, Omura M, Takagi T, Fukunaga R, Bandai Y, Tajima N, Nakamura Y. Lifestyle modification and prevention of type 2 diabetes in overweight Japanese with impaired fasting glucose levels: a randomized controlled trial. Arch Intern Med. 2011;171:1352-1360. [PMID: 21824948 DOI: 10.1001/archinternmed.2011.275] [Cited by in Crossref: 173] [Cited by in F6Publishing: 188] [Article Influence: 15.7] [Reference Citation Analysis]
Number Citing Articles
1 Hao J, Yao Q, Lin Y, Sun Y, Zhang B, Hu M, Zhang J, Zhao N, Pei J, Liu Z, Zhu C. Cost-effectiveness of two screening strategies based on Chinese diabetes risk score for pre-diabetes in China. Front Public Health 2022;10. [DOI: 10.3389/fpubh.2022.1018084] [Reference Citation Analysis]
2 Yeung KF, Lee YQ, Chong MFF, Gandhi M, Lam AYR, Julianty S, Tan GCS, Ho ETL, Goh SY, Tan GSW, Shum EJW, Finkelstein EA, Jafar TH, van Dam RM, Teoh YL, Thumboo J, Bee YM. Baseline characteristics of participants in the Pre-Diabetes Interventions and Continued Tracking to Ease-out Diabetes (Pre-DICTED) Program. BMJ Open Diabetes Res Care 2022;10:e002966. [PMID: 36220198 DOI: 10.1136/bmjdrc-2022-002966] [Reference Citation Analysis]
3 Uchida T, Kanamori T, Teramoto T, Nonaka Y, Tanaka H, Nakamura S, Murayama N, Kaluri R. Identifying Glucose Metabolism Status in Nondiabetic Japanese Adults Using Machine Learning Model with Simple Questionnaire. Computational and Mathematical Methods in Medicine 2022;2022:1-10. [DOI: 10.1155/2022/1026121] [Reference Citation Analysis]
4 Lee C, Han KD, Yoo J, Park K, Oh SY. The relationship between glycemic status and the risk of third, fourth, and sixth cranial nerve palsy: a nationwide population-based study (2009-2018).. [DOI: 10.21203/rs.3.rs-1860127/v1] [Reference Citation Analysis]
5 Wareham NJ. Personalised prevention of type 2 diabetes. Diabetologia 2022. [PMID: 35916901 DOI: 10.1007/s00125-022-05774-7] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Leal J, Becker F, Lim LL, Holman RR, Gray AM. Health utilities in Chinese patients with coronary heart disease and impaired glucose tolerance (ACE): A longitudinal analysis of a randomized, double-blind, placebo-controlled trial. J Diabetes 2022;14:455-64. [PMID: 35876124 DOI: 10.1111/1753-0407.13294] [Reference Citation Analysis]
7 Sun C, Lei Y, Lin Z, Li S, Wang M, Gu J. Effects of self-care programs on the incidence of diabetes among adults with prediabetes: A systematic review and meta-analysis of randomised controlled trials. J Clin Nurs 2022. [PMID: 35655374 DOI: 10.1111/jocn.16384] [Reference Citation Analysis]
8 Zhou R, Cui Y, Zhang Y, De J, An X, Duan Y, Zhang Y, Kang X, Lian F. The Long-Term Effects of Non-Pharmacological Interventions on Diabetes and Chronic Complication Outcomes in Patients With Hyperglycemia: A Systematic Review and Meta-Analysis. Front Endocrinol 2022;13:838224. [DOI: 10.3389/fendo.2022.838224] [Reference Citation Analysis]
9 Mathews E, Sathish T, Joseph A, Kodapally B, Thulaseedharan JV, Narayan KV, Oldenburg B, Thankappan KR. Effectiveness and implementation of a lifestyle modification intervention for women with isolated impaired fasting glucose: Study protocol for a hybrid type 2 study in Kerala, India. Wellcome Open Res 2022;7:62. [DOI: 10.12688/wellcomeopenres.17631.1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
10 Li N, Lu C, Ma Y, Wang X, Ling Y, Yin Y, Li S, Huang J, Yu L, Dong W, He H, Kang M, Ma L, Gu M, Zhao L, Huang Y, Liu F, Wang Y, Gai X, Jiang J, Peng Y, Ding X. Factors Associated with Progression of Different Prediabetic Status to Diabetes: A Community-based Cohort Study. Diabetes Res Clin Pract 2022;:109193. [PMID: 35032561 DOI: 10.1016/j.diabres.2022.109193] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
11 Echouffo-Tcheugui JB, Selvin E. Prediabetes and What It Means: The Epidemiological Evidence. Annu Rev Public Health 2021;42:59-77. [PMID: 33355476 DOI: 10.1146/annurev-publhealth-090419-102644] [Cited by in Crossref: 24] [Cited by in F6Publishing: 29] [Article Influence: 24.0] [Reference Citation Analysis]
12 Kuwahara K, Yamamoto S, Honda T, Nakagawa T, Ishikawa H, Hayashi T, Mizoue T. Improving and maintaining healthy lifestyles are associated with a lower risk of diabetes: A large cohort study. J Diabetes Investig 2021. [PMID: 34786886 DOI: 10.1111/jdi.13713] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
13 Hassen HY, Ndejjo R, Musinguzi G, Van Geertruyden JP, Abrams S, Bastiaens H. Effectiveness of community-based cardiovascular disease prevention interventions to improve physical activity: A systematic review and meta-regression. Prev Med 2021;153:106797. [PMID: 34508731 DOI: 10.1016/j.ypmed.2021.106797] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
14 Oe M, Fujihara K, Harada-Yamada M, Osawa T, Kitazawa M, Matsubayashi Y, Sato T, Yaguchi Y, Iwanaga M, Seida H, Yamada T, Sone H. Impact of prior cerebrovascular disease and glucose status on incident cerebrovascular disease in Japanese. Cardiovasc Diabetol 2021;20:174. [PMID: 34479567 DOI: 10.1186/s12933-021-01367-7] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
15 Colagiuri S. Definition and Classification of Diabetes and Prediabetes and Emerging Data on Phenotypes. Endocrinology and Metabolism Clinics of North America 2021;50:319-36. [DOI: 10.1016/j.ecl.2021.06.004] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 4.0] [Reference Citation Analysis]
16 Sathish T, Tapp RJ, Shaw JE. Do lifestyle interventions reduce diabetes incidence in people with isolated impaired fasting glucose? Diabetes Obes Metab 2021;23:2827-8. [PMID: 34432366 DOI: 10.1111/dom.14529] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
17 Jonas DE, Crotty K, Yun JDY, Middleton JC, Feltner C, Taylor-Phillips S, Barclay C, Dotson A, Baker C, Balio CP, Voisin CE, Harris RP. Screening for Prediabetes and Type 2 Diabetes: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force. JAMA 2021;326:744-60. [PMID: 34427595 DOI: 10.1001/jama.2021.10403] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 11.0] [Reference Citation Analysis]
18 Moon S, Jang JY, Kim Y, Oh CM. Development and validation of a new diabetes index for the risk classification of present and new-onset diabetes: multicohort study. Sci Rep 2021;11:15748. [PMID: 34344964 DOI: 10.1038/s41598-021-95341-8] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
19 Gong Q, Zhang P, Wang J, Gregg EW, Cheng YJ, Li G, Bennett PH; Da Qing Diabetes Prevention Outcome Study Group. Efficacy of lifestyle intervention in adults with impaired glucose tolerance with and without impaired fasting plasma glucose: A post hoc analysis of Da Qing Diabetes Prevention Outcome Study. Diabetes Obes Metab 2021;23:2385-94. [PMID: 34212465 DOI: 10.1111/dom.14481] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
20 Weber MB, Hassan S, Quarells R, Shah M. Prevention of Type 2 Diabetes. Endocrinol Metab Clin North Am 2021;50:387-400. [PMID: 34399952 DOI: 10.1016/j.ecl.2021.05.003] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
21 Araki E, Goto A, Kondo T, Noda M, Noto H, Origasa H, Osawa H, Taguchi A, Tanizawa Y, Tobe K, Yoshioka N. Japanese Clinical Practice Guideline for Diabetes 2019. J Diabetes Investig 2020;11:1020-76. [PMID: 33021749 DOI: 10.1111/jdi.13306] [Cited by in Crossref: 80] [Cited by in F6Publishing: 87] [Article Influence: 80.0] [Reference Citation Analysis]
22 Weber MB, Gujral UP, Jagannathan R, Shah M. Lifestyle Interventions for Diabetes Prevention in South Asians: Current Evidence and Opportunities. Curr Diab Rep 2021;21:23. [PMID: 34097137 DOI: 10.1007/s11892-021-01393-5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
23 Sengupta B, Bhattacharjya H. Validation of Indian Diabetes Risk Score for Screening Prediabetes in West Tripura District of India. Indian J Community Med 2021;46:30-4. [PMID: 34035572 DOI: 10.4103/ijcm.IJCM_136_20] [Reference Citation Analysis]
24 Fujii H, Funakoshi S, Maeda T, Satoh A, Kawazoe M, Ishida S, Yoshimura C, Yokota S, Tada K, Takahashi K, Ito K, Yasuno T, Okutsu S, Mukoubara S, Nakashima H, Nabeshima S, Kondo S, Fujita M, Masutani K, Arima H, Kawanami D. Eating Speed and Incidence of Diabetes in a Japanese General Population: ISSA-CKD. J Clin Med 2021;10:1949. [PMID: 34062802 DOI: 10.3390/jcm10091949] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
25 Święcicka-Klama A, Połtyn-Zaradna K, Szuba A, Zatońska K. The Natural Course of Impaired Fasting Glucose. Adv Exp Med Biol 2021;1324:41-50. [PMID: 32767267 DOI: 10.1007/5584_2020_571] [Cited by in Crossref: 4] [Article Influence: 4.0] [Reference Citation Analysis]
26 Kheniser K, Saxon DR, Kashyap SR. Long-Term Weight Loss Strategies for Obesity. J Clin Endocrinol Metab 2021;106:1854-66. [PMID: 33595666 DOI: 10.1210/clinem/dgab091] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 9.0] [Reference Citation Analysis]
27 Sampson M, Clark A, Bachmann M, Garner N, Irvine L, Howe A, Greaves C, Auckland S, Smith J, Turner J, Rea D, Rayman G, Dhatariya K, John WG, Barton G, Usher R, Ferns C, Pascale M; Norfolk Diabetes Prevention Study (NDPS) Group. Lifestyle Intervention With or Without Lay Volunteers to Prevent Type 2 Diabetes in People With Impaired Fasting Glucose and/or Nondiabetic Hyperglycemia: A Randomized Clinical Trial. JAMA Intern Med 2021;181:168-78. [PMID: 33136119 DOI: 10.1001/jamainternmed.2020.5938] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 13.0] [Reference Citation Analysis]
28 Powell LH, Kaufmann PG, Freedland KE. Hypothesized Pathway and Bias. Behavioral Clinical Trials for Chronic Diseases 2021. [DOI: 10.1007/978-3-030-39330-4_4] [Reference Citation Analysis]
29 Powell LH, Kaufmann PG, Freedland KE. Clinical Significance. Behavioral Clinical Trials for Chronic Diseases 2021. [DOI: 10.1007/978-3-030-39330-4_5] [Reference Citation Analysis]
30 Smokovski I. Diabetes Drivers. Managing Diabetes in Low Income Countries 2021. [DOI: 10.1007/978-3-030-51469-3_2] [Reference Citation Analysis]
31 Othman N, Wong YY, Lean QY, Mohd Noor N, Neoh CF. Factors affecting self-management among adolescents and youths with type 2 diabetes mellitus: A meta-synthesis. European Journal of Integrative Medicine 2020;40:101228. [DOI: 10.1016/j.eujim.2020.101228] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
32 Jambi H, Enani S, Malibary M, Bahijri S, Eldakhakhny B, Al-Ahmadi J, Al Raddadi R, Ajabnoor G, Boraie A, Tuomilehto J. The Association Between Dietary Habits and Other Lifestyle Indicators and Dysglycemia in Saudi Adults Free of Previous Diagnosis of Diabetes. Nutr Metab Insights 2020;13:1178638820965258. [PMID: 33116569 DOI: 10.1177/1178638820965258] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
33 Huang Q, Fang Q, Hu Z. A P4 Medicine Perspective of Gut Microbiota and Prediabetes: Systems Analysis and Personalized Intervention. J Transl Int Med 2020;8:119-30. [PMID: 33062587 DOI: 10.2478/jtim-2020-0020] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
34 Beulens J, Rutters F, Rydén L, Schnell O, Mellbin L, Hart HE, Vos RC. Risk and management of pre-diabetes. Eur J Prev Cardiol 2019;26:47-54. [PMID: 31766914 DOI: 10.1177/2047487319880041] [Cited by in Crossref: 30] [Cited by in F6Publishing: 35] [Article Influence: 15.0] [Reference Citation Analysis]
35 Yau JW, Thor SM, Ramadas A. Nutritional Strategies in Prediabetes: A Scoping Review of Recent Evidence. Nutrients 2020;12:E2990. [PMID: 33003593 DOI: 10.3390/nu12102990] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 3.5] [Reference Citation Analysis]
36 Alateeq MA, Aljohani M, Kinani SS, Aljabr IA, Alduayji AA, Aloud A, Alzahrani E, Alharbi K. The Prediabetes Outcome at National Guard Primary Health Care Centers in Riyadh, Saudi Arabia: Retrospective Chart Review. Cureus 2020;12:e10227. [PMID: 33042670 DOI: 10.7759/cureus.10227] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
37 Araki E, Goto A, Kondo T, Noda M, Noto H, Origasa H, Osawa H, Taguchi A, Tanizawa Y, Tobe K, Yoshioka N. Japanese Clinical Practice Guideline for Diabetes 2019. Diabetol Int 2020;11:165-223. [PMID: 32802702 DOI: 10.1007/s13340-020-00439-5] [Cited by in Crossref: 97] [Cited by in F6Publishing: 114] [Article Influence: 48.5] [Reference Citation Analysis]
38 Bell K, Shaw JE, Maple-brown L, Ferris W, Gray S, Murfet G, Flavel R, Maynard B, Ryrie H, Pritchard B, Freeman R, Gordon BA. A position statement on screening and management of prediabetes in adults in primary care in Australia. Diabetes Research and Clinical Practice 2020;164:108188. [DOI: 10.1016/j.diabres.2020.108188] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 6.0] [Reference Citation Analysis]
39 Nano J, Dhana K, Asllanaj E, Sijbrands E, Ikram MA, Dehghan A, Muka T, Franco OH. Trajectories of BMI Before Diagnosis of Type 2 Diabetes: The Rotterdam Study. Obesity (Silver Spring) 2020;28:1149-56. [PMID: 32379398 DOI: 10.1002/oby.22802] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
40 Kivelä J, Wikström K, Virtanen E, Georgoulis M, Cardon G, Civeira F, Iotova V, Karuranga E, Ko W, Liatis S, Makrilakis K, Manios Y, Mateo-Gallego R, Nanasi A, Rurik I, Tankova T, Tsochev K, Van Stappen V, Lindström J; Feel4Diabetes research group. Obtaining evidence base for the development of Feel4Diabetes intervention to prevent type 2 diabetes - a narrative literature review. BMC Endocr Disord 2020;20:140. [PMID: 32164690 DOI: 10.1186/s12902-019-0468-y] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 4.5] [Reference Citation Analysis]
41 Bahijri S, Al-Raddadi R, Ajabnoor G, Jambi H, Al Ahmadi J, Borai A, Barengo NC, Tuomilehto J. Dysglycemia risk score in Saudi Arabia: A tool to identify people at high future risk of developing type 2 diabetes. J Diabetes Investig 2020;11:844-55. [PMID: 31957345 DOI: 10.1111/jdi.13213] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
42 Campbell MD, Sathish T, Zimmet PZ, Thankappan KR, Oldenburg B, Owens DR, Shaw JE, Tapp RJ. Benefit of lifestyle-based T2DM prevention is influenced by prediabetes phenotype. Nat Rev Endocrinol 2020;16:395-400. [DOI: 10.1038/s41574-019-0316-1] [Cited by in Crossref: 34] [Cited by in F6Publishing: 39] [Article Influence: 17.0] [Reference Citation Analysis]
43 Andes LJ, Cheng YJ, Rolka DB, Gregg EW, Imperatore G. Prevalence of Prediabetes Among Adolescents and Young Adults in the United States, 2005-2016. JAMA Pediatr. 2020;174:e194498. [PMID: 31790544 DOI: 10.1001/jamapediatrics.2019.4498] [Cited by in Crossref: 117] [Cited by in F6Publishing: 127] [Article Influence: 58.5] [Reference Citation Analysis]
44 Roncero-ramos I, Alcala-diaz JF, Rangel-zuñiga OA, Gomez-delgado F, Jimenez-lucena R, García-rios A, Vals-delgado C, Romero-baldonado C, Luque RM, Ordovas JM, Perez-martinez P, Camargo A, Lopez-miranda J. Prediabetes diagnosis criteria, type 2 diabetes risk and dietary modulation: The CORDIOPREV study. Clinical Nutrition 2020;39:492-500. [DOI: 10.1016/j.clnu.2019.02.027] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
45 Dong Y, Xing Y, Sun J, Sun W, Xu Y, Quan C. Baicalein Alleviates Liver Oxidative Stress and Apoptosis Induced by High-Level Glucose through the Activation of the PERK/Nrf2 Signaling Pathway. Molecules 2020;25:E599. [PMID: 32019168 DOI: 10.3390/molecules25030599] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 8.5] [Reference Citation Analysis]
46 Pancer J, Wu N, Mahmoud I, Dasgupta K. Pharmacological intervention for diabetes after pregnancy prevention in women with prior gestational diabetes: A scoping review. Diabetes Res Clin Pract 2020;160:107998. [PMID: 31911249 DOI: 10.1016/j.diabres.2020.107998] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
47 Moon S, Jang J, Kim Y, Chung W, Oh C. Development and Validation of a New Risk Prediction Model for New-Onset Diabetes: Multicohort Study. SSRN Journal. [DOI: 10.2139/ssrn.3719888] [Reference Citation Analysis]
48 Lee CMY, Colagiuri S, Woodward M, Gregg EW, Adams R, Azizi F, Gabriel R, Gill TK, Gonzalez C, Hodge A, Jacobs Jr DR Jr, Joseph JJ, Khalili D, Magliano DJ, Mehlig K, Milne R, Mishra G, Mongraw-Chaffin M, Pasco JA, Sakurai M, Schreiner PJ, Selvin E, Shaw JE, Wittert G, Yatsuya H, Huxley RR. Comparing different definitions of prediabetes with subsequent risk of diabetes: an individual participant data meta-analysis involving 76 513 individuals and 8208 cases of incident diabetes. BMJ Open Diabetes Res Care 2019;7:e000794. [PMID: 31908797 DOI: 10.1136/bmjdrc-2019-000794] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 6.3] [Reference Citation Analysis]
49 Harreiter J, Roden M. [Diabetes mellitus-Definition, classification, diagnosis, screening and prevention (Update 2019)]. Wien Klin Wochenschr 2019;131:6-15. [PMID: 30980151 DOI: 10.1007/s00508-019-1450-4] [Cited by in Crossref: 54] [Cited by in F6Publishing: 57] [Article Influence: 18.0] [Reference Citation Analysis]
50 Khan RMM, Chua ZJY, Tan JC, Yang Y, Liao Z, Zhao Y. From Pre-Diabetes to Diabetes: Diagnosis, Treatments and Translational Research. Medicina (Kaunas). 2019;55. [PMID: 31470636 DOI: 10.3390/medicina55090546] [Cited by in Crossref: 77] [Cited by in F6Publishing: 85] [Article Influence: 25.7] [Reference Citation Analysis]
51 Al-Zahrani JM, Aldiab A, Aldossari KK, Al-Ghamdi S, Batais MA, Javad S, Nooruddin S, Zahid N, Razzak HA, El-Metwally A. Prevalence of Prediabetes, Diabetes and Its Predictors among Females in Alkharj, Saudi Arabia: A Cross-Sectional Study. Ann Glob Health 2019;85:109. [PMID: 31348623 DOI: 10.5334/aogh.2467] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
52 Shaw JE. Prediabetes: lifestyle, pharmacotherapy or regulation? Ther Adv Endocrinol Metab 2019;10:2042018819863020. [PMID: 31321022 DOI: 10.1177/2042018819863020] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
53 Sheng Z, Cao JY, Pang YC, Xu HC, Chen JW, Yuan JH, Wang R, Zhang CS, Wang LX, Dong J. Effects of Lifestyle Modification and Anti-diabetic Medicine on Prediabetes Progress: A Systematic Review and Meta-Analysis. Front Endocrinol (Lausanne) 2019;10:455. [PMID: 31354627 DOI: 10.3389/fendo.2019.00455] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 4.7] [Reference Citation Analysis]
54 Shivashankar R, Singh K, Aravind LR, Tandon N. Diabetes Management in Asia. In: Rodriguez-saldana J, editor. The Diabetes Textbook. Cham: Springer International Publishing; 2019. pp. 239-53. [DOI: 10.1007/978-3-030-11815-0_16] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
55 Yamaoka K, Nemoto A, Tango T. Comparison of the Effectiveness of Lifestyle Modification with Other Treatments on the Incidence of Type 2 Diabetes in People at High Risk: A Network Meta-Analysis. Nutrients 2019;11:E1373. [PMID: 31248094 DOI: 10.3390/nu11061373] [Cited by in Crossref: 8] [Cited by in F6Publishing: 11] [Article Influence: 2.7] [Reference Citation Analysis]
56 Sakane N, Kotani K, Suganuma A, Takahashi K, Sato J, Suzuki S, Izumi K, Kato M, Noda M, Nirengi S, Kuzuya H. Prevention of Metabolic Syndrome by Telephone-Delivered Lifestyle Intervention in a Real-World Setting: Sub-Analysis of a Cluster-Randomized Trial. Metab Syndr Relat Disord 2019;17:355-61. [PMID: 31145031 DOI: 10.1089/met.2018.0130] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
57 Gong Q, Zhang P, Wang J, Ma J, An Y, Chen Y, Zhang B, Feng X, Li H, Chen X, Cheng YJ, Gregg EW, Hu Y, Bennett PH, Li G; Da Qing Diabetes Prevention Study Group. Morbidity and mortality after lifestyle intervention for people with impaired glucose tolerance: 30-year results of the Da Qing Diabetes Prevention Outcome Study. Lancet Diabetes Endocrinol 2019;7:452-61. [PMID: 31036503 DOI: 10.1016/S2213-8587(19)30093-2] [Cited by in Crossref: 182] [Cited by in F6Publishing: 204] [Article Influence: 60.7] [Reference Citation Analysis]
58 Schmidt MI, Bracco PA, Yudkin JS, Bensenor IM, Griep RH, Barreto SM, Castilhos CD, Duncan BB. Intermediate hyperglycaemia to predict progression to type 2 diabetes (ELSA-Brasil): an occupational cohort study in Brazil. The Lancet Diabetes & Endocrinology 2019;7:267-77. [DOI: 10.1016/s2213-8587(19)30058-0] [Cited by in Crossref: 41] [Cited by in F6Publishing: 42] [Article Influence: 13.7] [Reference Citation Analysis]
59 Tuomilehto J. Definitions of intermediate hyperglycaemia and progression to type 2 diabetes. The Lancet Diabetes & Endocrinology 2019;7:243-5. [DOI: 10.1016/s2213-8587(19)30064-6] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
60 Leal J, Morrow LM, Khurshid W, Pagano E, Feenstra T. Decision models of prediabetes populations: A systematic review. Diabetes Obes Metab 2019;21:1558-69. [PMID: 30828927 DOI: 10.1111/dom.13684] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 4.7] [Reference Citation Analysis]
61 Hasegawa Y, Nakagami T, Oya J, Takahashi K, Isago C, Kurita M, Tanaka Y, Ito A, Kasahara T, Uchigata Y. Body Weight Reduction of 5% Improved Blood Pressure and Lipid Profiles in Obese Men and Blood Glucose in Obese Women: A Four-Year Follow-up Observational Study. Metab Syndr Relat Disord 2019;17:250-8. [PMID: 30839239 DOI: 10.1089/met.2018.0115] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
62 Sathish T. Diabetes prevention and lifestyle intervention in resource-limited settings. Lancet Diabetes Endocrinol 2019;7:165-7. [PMID: 30737179 DOI: 10.1016/S2213-8587(19)30027-0] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]
63 Joseph JJ, Bennett A, Echouffo Tcheugui JB, Effoe VS, Odei JB, Hidalgo B, Dulin A, Safford MM, Cummings DM, Cushman M, Carson AP. Ideal cardiovascular health, glycaemic status and incident type 2 diabetes mellitus: the REasons for Geographic and Racial Differences in Stroke (REGARDS) study. Diabetologia. 2019;62:426-437. [PMID: 30643923 DOI: 10.1007/s00125-018-4792-y] [Cited by in Crossref: 24] [Cited by in F6Publishing: 25] [Article Influence: 8.0] [Reference Citation Analysis]
64 Dong Y, Zhang B, Sun W, Xing Y. Intervention of Prediabetes by Flavonoids From Oroxylum indicum. Bioactive Food as Dietary Interventions for Diabetes. Elsevier; 2019. pp. 559-75. [DOI: 10.1016/b978-0-12-813822-9.00036-9] [Cited by in Crossref: 9] [Article Influence: 3.0] [Reference Citation Analysis]
65 Onoue T, Goto M, Kobayashi T, Tominaga T, Ando M, Honda H, Yoshida Y, Tosaki T, Yokoi H, Kato S, Maruyama S, Arima H. Randomized controlled trial for assessment of Internet of Things system to guide intensive glucose control in diabetes outpatients: Nagoya Health Navigator Study protocol. Nagoya J Med Sci 2017;79:323-9. [PMID: 28878437 DOI: 10.18999/nagjms.79.3.323] [Cited by in F6Publishing: 9] [Reference Citation Analysis]
66 Echouffo-Tcheugui JB, Kengne AP, Ali MK. Issues in Defining the Burden of Prediabetes Globally. Curr Diab Rep 2018;18:105. [PMID: 30229351 DOI: 10.1007/s11892-018-1089-y] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
67 Bombak AE, Riediger ND, Bensley J, Ankomah S, Mudryj A. A systematic search and critical thematic, narrative review of lifestyle interventions for the prevention and management of diabetes. Critical Public Health 2020;30:103-14. [DOI: 10.1080/09581596.2018.1516033] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 1.8] [Reference Citation Analysis]
68 Guess ND. Dietary Interventions for the Prevention of Type 2 Diabetes in High-Risk Groups: Current State of Evidence and Future Research Needs. Nutrients 2018;10:E1245. [PMID: 30200572 DOI: 10.3390/nu10091245] [Cited by in Crossref: 29] [Cited by in F6Publishing: 30] [Article Influence: 7.3] [Reference Citation Analysis]
69 Uusitupa M, Lindström J, Tuomilehto J. Prevention of type 2 diabetes-success story that is waiting for next steps. Eur J Clin Nutr 2018;72:1260-6. [PMID: 30185842 DOI: 10.1038/s41430-018-0223-x] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
70 Glechner A, Keuchel L, Affengruber L, Titscher V, Sommer I, Matyas N, Wagner G, Kien C, Klerings I, Gartlehner G. Effects of lifestyle changes on adults with prediabetes: A systematic review and meta-analysis. Prim Care Diabetes 2018;12:393-408. [PMID: 30076075 DOI: 10.1016/j.pcd.2018.07.003] [Cited by in Crossref: 71] [Cited by in F6Publishing: 75] [Article Influence: 17.8] [Reference Citation Analysis]
71 Bodai BI, Nakata TE, Wong WT, Clark DR, Lawenda S, Tsou C, Liu R, Shiue L, Cooper N, Rehbein M, Ha BP, Mckeirnan A, Misquitta R, Vij P, Klonecke A, Mejia CS, Dionysian E, Hashmi S, Greger M, Stoll S, Campbell TM. Lifestyle Medicine: A Brief Review of Its Dramatic Impact on Health and Survival. Perm J 2018;22:17-025. [PMID: 29035175 DOI: 10.7812/TPP/17-025] [Cited by in Crossref: 42] [Cited by in F6Publishing: 62] [Article Influence: 10.5] [Reference Citation Analysis]
72 Thankappan KR, Sathish T, Tapp RJ, Shaw JE, Lotfaliany M, Wolfe R, Absetz P, Mathews E, Aziz Z, Williams ED, Fisher EB, Zimmet PZ, Mahal A, Balachandran S, D'Esposito F, Sajeev P, Thomas E, Oldenburg B. A peer-support lifestyle intervention for preventing type 2 diabetes in India: A cluster-randomized controlled trial of the Kerala Diabetes Prevention Program. PLoS Med 2018;15:e1002575. [PMID: 29874236 DOI: 10.1371/journal.pmed.1002575] [Cited by in Crossref: 77] [Cited by in F6Publishing: 80] [Article Influence: 19.3] [Reference Citation Analysis]
73 Onishi Y, Hayashi T, Sato KK, Leonetti DL, Kahn SE, Fujimoto WY, Boyko EJ. Natural history of impaired glucose tolerance in Japanese Americans: Change in visceral adiposity is associated with remission from impaired glucose tolerance to normal glucose tolerance. Diabetes Res Clin Pract 2018;142:303-11. [PMID: 29859271 DOI: 10.1016/j.diabres.2018.05.045] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
74 Unwin N, Howitt C, Rose AM, Samuels TA, Hennis AJ, Hambleton IR. Prevalence and phenotype of diabetes and prediabetes using fasting glucose vs HbA1c in a Caribbean population. J Glob Health 2017;7:020407. [PMID: 28959440 DOI: 10.7189/jogh.07.020407] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 3.0] [Reference Citation Analysis]
75 Prebtani AP, Bajaj HS, Goldenberg R, Mullan Y. Reducing the Risk of Developing Diabetes. Canadian Journal of Diabetes 2018;42:S20-6. [DOI: 10.1016/j.jcjd.2017.10.033] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.5] [Reference Citation Analysis]
76 Haneda M, Noda M, Origasa H, Noto H, Yabe D, Fujita Y, Goto A, Kondo T, Araki E. Japanese Clinical Practice Guideline for Diabetes 2016. Diabetol Int 2018;9:1-45. [PMID: 30603347 DOI: 10.1007/s13340-018-0345-3] [Cited by in Crossref: 126] [Cited by in F6Publishing: 105] [Article Influence: 31.5] [Reference Citation Analysis]
77 Haneda M, Noda M, Origasa H, Noto H, Yabe D, Fujita Y, Goto A, Kondo T, Araki E. Japanese Clinical Practice Guideline for Diabetes 2016. J Diabetes Investig 2018. [PMID: 29582574 DOI: 10.1111/jdi.12810] [Cited by in Crossref: 137] [Cited by in F6Publishing: 144] [Article Influence: 34.3] [Reference Citation Analysis]
78 Penn L, Rodrigues A, Haste A, Marques MM, Budig K, Sainsbury K, Bell R, Araújo-Soares V, White M, Summerbell C, Goyder E, Brennan A, Adamson AJ, Sniehotta FF. NHS Diabetes Prevention Programme in England: formative evaluation of the programme in early phase implementation. BMJ Open 2018;8:e019467. [PMID: 29467134 DOI: 10.1136/bmjopen-2017-019467] [Cited by in Crossref: 35] [Cited by in F6Publishing: 38] [Article Influence: 8.8] [Reference Citation Analysis]
79 Montgomery B. The Pillars of Prevention: Discover, Advocate, and Educate. Diabetes Spectr 2018;31:99-104. [PMID: 29456433 DOI: 10.2337/ds17-0078] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
80 Yin Z, Perry J, Duan X, He M, Johnson R, Feng Y, Strand M. Cultural adaptation of an evidence-based lifestyle intervention for diabetes prevention in Chinese women at risk for diabetes: results of a randomized trial. International Health 2018;10:391-400. [DOI: 10.1093/inthealth/ihx072] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
81 Khetan AK, Rajagopalan S. Prediabetes. Can J Cardiol 2018;34:615-23. [PMID: 29731022 DOI: 10.1016/j.cjca.2017.12.030] [Cited by in Crossref: 42] [Cited by in F6Publishing: 43] [Article Influence: 10.5] [Reference Citation Analysis]
82 Park S, Woo M, Lim HJ, Chon S, Woo J. A Nutrition Intervention Focused on Weight Management Through Lifestyle Improvements in Prediabetic Subjects. Clin Nutr Res 2018;7:69. [DOI: 10.7762/cnr.2018.7.1.69] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
83 Knowler WC. Prevention of Type 2 Diabetes. Endocrinology 2018. [DOI: 10.1007/978-3-319-27317-4_16-1] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
84 Moher M. Diabetes Mellitus. Integrative Medicine 2018. [DOI: 10.1016/b978-0-323-35868-2.00033-5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
85 Knowler WC. Prevention of Type 2 Diabetes. Endocrinology 2018. [DOI: 10.1007/978-3-319-45015-5_16] [Reference Citation Analysis]
86 Haw JS, Galaviz KI, Straus AN, Kowalski AJ, Magee MJ, Weber MB, Wei J, Narayan KMV, Ali MK. Long-term Sustainability of Diabetes Prevention Approaches: A Systematic Review and Meta-analysis of Randomized Clinical Trials. JAMA Intern Med 2017;177:1808-17. [PMID: 29114778 DOI: 10.1001/jamainternmed.2017.6040] [Cited by in Crossref: 167] [Cited by in F6Publishing: 173] [Article Influence: 33.4] [Reference Citation Analysis]
87 Hemmingsen B, Gimenez-Perez G, Mauricio D, Roqué I Figuls M, Metzendorf MI, Richter B. Diet, physical activity or both for prevention or delay of type 2 diabetes mellitus and its associated complications in people at increased risk of developing type 2 diabetes mellitus. Cochrane Database Syst Rev 2017;12:CD003054. [PMID: 29205264 DOI: 10.1002/14651858.CD003054.pub4] [Cited by in Crossref: 54] [Cited by in F6Publishing: 87] [Article Influence: 10.8] [Reference Citation Analysis]
88 Roberts S, Barry E, Craig D, Airoldi M, Bevan G, Greenhalgh T. Preventing type 2 diabetes: systematic review of studies of cost-effectiveness of lifestyle programmes and metformin, with and without screening, for pre-diabetes. BMJ Open 2017;7:e017184. [PMID: 29146638 DOI: 10.1136/bmjopen-2017-017184] [Cited by in Crossref: 52] [Cited by in F6Publishing: 54] [Article Influence: 10.4] [Reference Citation Analysis]
89 Ma C, Avenell A, Bolland M, Hudson J, Stewart F, Robertson C, Sharma P, Fraser C, MacLennan G. Effects of weight loss interventions for adults who are obese on mortality, cardiovascular disease, and cancer: systematic review and meta-analysis. BMJ 2017;359:j4849. [PMID: 29138133 DOI: 10.1136/bmj.j4849] [Cited by in Crossref: 221] [Cited by in F6Publishing: 233] [Article Influence: 44.2] [Reference Citation Analysis]
90 Edwards J, Hosseinzadeh H. The impact of structured physical activity on glycaemic control in diabetes prevention programmes: A systematic review. Proceedings of Singapore Healthcare 2018;27:193-204. [DOI: 10.1177/2010105817739924] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 2.2] [Reference Citation Analysis]
91 Sakane N. Diabetes prevention in the real world: Insights from the JDPP and J-DOIT1. J Gen Fam Med 2017;18:325-30. [PMID: 29264060 DOI: 10.1002/jgf2.85] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
92 Leal J, Khurshid W, Pagano E, Feenstra T. Computer simulation models of pre-diabetes populations: a systematic review protocol. BMJ Open 2017;7:e014954. [PMID: 28982807 DOI: 10.1136/bmjopen-2016-014954] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
93 Narayan KM. Type 2 Diabetes: Why We Are Winning the Battle but Losing the War? 2015 Kelly West Award Lecture. Diabetes Care. 2016;39:653-663. [PMID: 27208372 DOI: 10.2337/dc16-0205] [Cited by in Crossref: 45] [Cited by in F6Publishing: 48] [Article Influence: 9.0] [Reference Citation Analysis]
94 Saito M, Shimazaki Y, Nonoyama T, Tadokoro Y. Association between dental visits for periodontal treatment and type 2 diabetes mellitus in an elderly Japanese cohort. J Clin Periodontol 2017;44:1133-9. [DOI: 10.1111/jcpe.12804] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
95 Okada R, Tsushita K, Wakai K, Ishizaka Y, Kato K, Wada T, Watanabe K. Lower risk of progression from prediabetes to diabetes with health checkup with lifestyle education: Japan Ningen Dock study. Nutrition, Metabolism and Cardiovascular Diseases 2017;27:679-87. [DOI: 10.1016/j.numecd.2017.06.004] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
96 Zhang H, Wang C, Ren Y, Wang B, Yang X, Zhao Y, Han C, Zhou J, Zhang L, Qi M, Zhai Y, Pang C, Yin L, Zhao J, Hu D, Zhang M. A risk-score model for predicting risk of type 2 diabetes mellitus in a rural Chinese adult population: A cohort study with a 6-year follow-up. Diabetes Metab Res Rev 2017;33:e2911. [DOI: 10.1002/dmrr.2911] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.4] [Reference Citation Analysis]
97 Keselman B, Vergara M, Nyberg S, Nystrom FH. A randomized cross-over study of the acute effects of running 5 km on glucose, insulin, metabolic rate, cortisol and Troponin T. PLoS One 2017;12:e0179401. [PMID: 28622349 DOI: 10.1371/journal.pone.0179401] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.4] [Reference Citation Analysis]
98 Abate N, Chandalia M. Risk of Obesity-Related Cardiometabolic Complications in Special Populations: A Crisis in Asians. Gastroenterology 2017;152:1647-55. [PMID: 28192110 DOI: 10.1053/j.gastro.2017.01.046] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 3.2] [Reference Citation Analysis]
99 Kerrison G, Gillis RB, Jiwani SI, Alzahrani Q, Kok S, Harding SE, Shaw I, Adams GG. The Effectiveness of Lifestyle Adaptation for the Prevention of Prediabetes in Adults: A Systematic Review. J Diabetes Res 2017;2017:8493145. [PMID: 28567425 DOI: 10.1155/2017/8493145] [Cited by in Crossref: 38] [Cited by in F6Publishing: 41] [Article Influence: 7.6] [Reference Citation Analysis]
100 Shahbazi S, Vahdat Shariatpanahi Z. Prevention of type 2 diabetes mellitus by changes in diet among subjects with abnormal glucose metabolism: a randomized clinical trial. Int J Diabetes Dev Ctries 2018;38:69-74. [DOI: 10.1007/s13410-017-0548-3] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
101 Neumann A, Lindholm L, Norberg M, Schoffer O, Klug SJ, Norström F. The cost-effectiveness of interventions targeting lifestyle change for the prevention of diabetes in a Swedish primary care and community based prevention program. Eur J Health Econ 2017;18:905-19. [PMID: 27913943 DOI: 10.1007/s10198-016-0851-9] [Cited by in Crossref: 25] [Cited by in F6Publishing: 22] [Article Influence: 4.2] [Reference Citation Analysis]
102 Kennedy R, Division of Endocrinology and Metabolism, University of Kentucky, Lexington, KY. Clinical Outcomes in Patients with Diabetes Mellitus Using a Medically Supervised Commercial Weight Reduction Program Compared to Standard Care in an Endocrine Specialty Clinic. JDO 2016;3:1-6. [DOI: 10.15436/2376-0494.16.838] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
103 Weber MB, Ranjani H, Staimez LR, Anjana RM, Ali MK, Narayan KM, Mohan V. The Stepwise Approach to Diabetes Prevention: Results From the D-CLIP Randomized Controlled Trial. Diabetes Care 2016;39:1760-7. [PMID: 27504014 DOI: 10.2337/dc16-1241] [Cited by in Crossref: 92] [Cited by in F6Publishing: 98] [Article Influence: 15.3] [Reference Citation Analysis]
104 Zimmet P, Alberti KG, Magliano DJ, Bennett PH. Diabetes mellitus statistics on prevalence and mortality: facts and fallacies. Nat Rev Endocrinol. 2016;12:616-622. [PMID: 27388988 DOI: 10.1038/nrendo.2016.105] [Cited by in Crossref: 388] [Cited by in F6Publishing: 400] [Article Influence: 64.7] [Reference Citation Analysis]
105 Singh K, Ranjani H, Rhodes E, Weber MB. International Models of Care that Address the Growing Diabetes Prevalence in Developing Countries. Curr Diab Rep 2016;16. [DOI: 10.1007/s11892-016-0768-9] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
106 Yang XJ, Zou SF, Xu Y, Li Y, Yang SS. The influence of intensive lifestyle intervention on patients with isolated impaired fasting glucose: a meta-analysis. J Adv Nurs 2016;72:2587-97. [PMID: 27237703 DOI: 10.1111/jan.13015] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
107 Hong JL, McNeill AM, He J, Chen Y, Brodovicz KG. Identification of impaired fasting glucose, healthcare utilization and progression to diabetes in the UK using the Clinical Practice Research Datalink (CPRD). Pharmacoepidemiol Drug Saf 2016;25:1375-86. [PMID: 27193175 DOI: 10.1002/pds.4007] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.2] [Reference Citation Analysis]
108 Barengo NC, Tuomilehto JO. How can we identify candidates at highest risk – to screen or not to screen? Herz 2016;41:175-83. [DOI: 10.1007/s00059-016-4417-5] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
109 Guess N, Perreault L, Kerege A, Strauss A, Bergman BC. Dietary Fatty Acids Differentially Associate with Fasting Versus 2-Hour Glucose Homeostasis: Implications for The Management of Subtypes of Prediabetes. PLoS One 2016;11:e0150148. [PMID: 26999667 DOI: 10.1371/journal.pone.0150148] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 2.5] [Reference Citation Analysis]
110 Hivert M, Knowler WC. Diabetes Prevention. The Genetics of Type 2 Diabetes and Related Traits 2016. [DOI: 10.1007/978-3-319-01574-3_25] [Reference Citation Analysis]
111 Balk EM, Earley A, Raman G, Avendano EA, Pittas AG, Remington PL. Combined Diet and Physical Activity Promotion Programs to Prevent Type 2 Diabetes Among Persons at Increased Risk: A Systematic Review for the Community Preventive Services Task Force. Ann Intern Med. 2015;163:437-451. [PMID: 26167912 DOI: 10.7326/m15-0452] [Cited by in Crossref: 187] [Cited by in F6Publishing: 206] [Article Influence: 26.7] [Reference Citation Analysis]
112 Goto A, Noda M, Sawada N, Kato M, Hidaka A, Mizoue T, Shimazu T, Yamaji T, Iwasaki M, Sasazuki S, Inoue M, Kadowaki T, Tsugane S; JPHC Study Group. High hemoglobin A1c levels within the non-diabetic range are associated with the risk of all cancers. Int J Cancer 2016;138:1741-53. [PMID: 26547128 DOI: 10.1002/ijc.29917] [Cited by in Crossref: 31] [Cited by in F6Publishing: 32] [Article Influence: 4.4] [Reference Citation Analysis]
113 Galaviz KI, Narayan KMV, Lobelo F, Weber MB. Lifestyle and the Prevention of Type 2 Diabetes: A Status Report. Am J Lifestyle Med 2018;12:4-20. [PMID: 30202378 DOI: 10.1177/1559827615619159] [Cited by in Crossref: 50] [Cited by in F6Publishing: 54] [Article Influence: 7.1] [Reference Citation Analysis]
114 Liu AY, Silvestre MP, Poppitt SD. Prevention of type 2 diabetes through lifestyle modification: is there a role for higher-protein diets? Adv Nutr 2015;6:665-73. [PMID: 26567192 DOI: 10.3945/an.115.008821] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 1.9] [Reference Citation Analysis]
115 Modesti PA, Galanti G, Cala' P, Calabrese M. Lifestyle interventions in preventing new type 2 diabetes in Asian populations. Intern Emerg Med 2016;11:375-84. [PMID: 26475162 DOI: 10.1007/s11739-015-1325-2] [Cited by in Crossref: 24] [Cited by in F6Publishing: 23] [Article Influence: 3.4] [Reference Citation Analysis]
116 Kanat M, DeFronzo RA, Abdul-Ghani MA. Treatment of prediabetes. World J Diabetes 2015; 6(12): 1207-1222 [PMID: 26464759 DOI: 10.4239/wjd.v6.i12.1207] [Cited by in CrossRef: 44] [Cited by in F6Publishing: 46] [Article Influence: 6.3] [Reference Citation Analysis]
117 Sakane N, Kotani K, Takahashi K, Sano Y, Tsuzaki K, Okazaki K, Sato J, Suzuki S, Morita S, Oshima Y, Izumi K, Kato M, Ishizuka N, Noda M, Kuzuya H. Effects of telephone-delivered lifestyle support on the development of diabetes in participants at high risk of type 2 diabetes: J-DOIT1, a pragmatic cluster randomised trial. BMJ Open 2015;5:e007316. [PMID: 26289448 DOI: 10.1136/bmjopen-2014-007316] [Cited by in Crossref: 20] [Cited by in F6Publishing: 24] [Article Influence: 2.9] [Reference Citation Analysis]
118 Fiorentino TV, Marini MA, Andreozzi F, Arturi F, Succurro E, Perticone M, Sciacqua A, Hribal ML, Perticone F, Sesti G. One-Hour Postload Hyperglycemia Is a Stronger Predictor of Type 2 Diabetes Than Impaired Fasting Glucose. J Clin Endocrinol Metab. 2015;100:3744-3751. [PMID: 26274345 DOI: 10.1210/jc.2015-2573] [Cited by in Crossref: 75] [Cited by in F6Publishing: 81] [Article Influence: 10.7] [Reference Citation Analysis]
119 Holt RI. The prevention of diabetes and cardiovascular disease in people with schizophrenia. Acta Psychiatr Scand 2015;132:86-96. [PMID: 25976975 DOI: 10.1111/acps.12443] [Cited by in Crossref: 22] [Cited by in F6Publishing: 23] [Article Influence: 3.1] [Reference Citation Analysis]
120 Tajima N, Noda M, Origasa H, Noto H, Yabe D, Fujita Y, Goto A, Fujimoto K, Sakamoto M, Haneda M. Evidence-based practice guideline for the treatment for diabetes in Japan 2013. Diabetol Int 2015;6:151-87. [DOI: 10.1007/s13340-015-0206-2] [Cited by in Crossref: 59] [Cited by in F6Publishing: 59] [Article Influence: 8.4] [Reference Citation Analysis]
121 Aroda VR, Getaneh A. Guiding diabetes screening and prevention: rationale, recommendations and remaining challenges. Expert Rev Endocrinol Metab 2015;10:381-98. [PMID: 30293496 DOI: 10.1586/17446651.2015.1054280] [Reference Citation Analysis]
122 Rautio N, Jokelainen J, Oksa H, Saaristo T, Peltonen M, Puolijoki H, Tuomilehto J, Vanhala M, Moilanen L, Uusitupa M, Keinänen-Kiukaanniemi S. Changes in glucose metabolism in people with different glucose metabolism disorders at baseline: follow-up results of a Finnish national diabetes prevention programme. Diabet Med 2015;32:1611-6. [PMID: 25864699 DOI: 10.1111/dme.12776] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
123 Cos FX, Barengo NC, Costa B, Mundet-Tudurí X, Lindström J, Tuomilehto JO; DE-PLAN Study Group. Screening for people with abnormal glucose metabolism in the European DE-PLAN project. Diabetes Res Clin Pract 2015;109:149-56. [PMID: 25931281 DOI: 10.1016/j.diabres.2015.04.016] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 1.9] [Reference Citation Analysis]
124 Bansal N. Prediabetes diagnosis and treatment: A review. World J Diabetes 2015; 6(2): 296-303 [PMID: 25789110 DOI: 10.4239/wjd.v6.i2.296] [Cited by in CrossRef: 243] [Cited by in F6Publishing: 258] [Article Influence: 34.7] [Reference Citation Analysis]
125 Hollander P, Spellman C. Controversies in Prediabetes: Do We Have a Diagnosis? Postgraduate Medicine 2015;124:109-18. [DOI: 10.3810/pgm.2012.07.2562] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 1.7] [Reference Citation Analysis]
126 Charvat H, Goto A, Goto M, Inoue M, Heianza Y, Arase Y, Sone H, Nakagami T, Song X, Qiao Q, Tuomilehto J, Tsugane S, Noda M, Inoue M. Impact of population aging on trends in diabetes prevalence: A meta-regression analysis of 160,000 Japanese adults. J Diabetes Investig 2015;6:533-42. [PMID: 26417410 DOI: 10.1111/jdi.12333] [Cited by in Crossref: 86] [Cited by in F6Publishing: 87] [Article Influence: 12.3] [Reference Citation Analysis]
127 Stevens JW, Khunti K, Harvey R, Johnson M, Preston L, Woods HB, Davies M, Goyder E. Preventing the progression to type 2 diabetes mellitus in adults at high risk: a systematic review and network meta-analysis of lifestyle, pharmacological and surgical interventions. Diabetes Res Clin Pract 2015;107:320-31. [PMID: 25638454 DOI: 10.1016/j.diabres.2015.01.027] [Cited by in Crossref: 86] [Cited by in F6Publishing: 98] [Article Influence: 12.3] [Reference Citation Analysis]
128 Nakata Y, Sasai H. Current review of intervention studies on obesity and the role of physical activity in weight control. JPFSM 2015;4:321-329. [DOI: 10.7600/jpfsm.4.321] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
129 Glechner A, Harreiter J, Gartlehner G, Rohleder S, Kautzky A, Tuomilehto J, Van Noord M, Kaminski-hartenthaler A, Kautzky-willer A. Sex-specific differences in diabetes prevention: a systematic review and meta-analysis. Diabetologia 2015;58:242-54. [DOI: 10.1007/s00125-014-3439-x] [Cited by in Crossref: 33] [Cited by in F6Publishing: 36] [Article Influence: 4.1] [Reference Citation Analysis]
130 Dawes D, Ashe M, Campbell K, Cave D, Elley CR, Kaczorowski J, Sohal P, Ur E, Dawes M. Preventing diabetes in primary care: a feasibility cluster randomized trial. Can J Diabetes 2015;39:111-6. [PMID: 25439501 DOI: 10.1016/j.jcjd.2014.08.004] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.9] [Reference Citation Analysis]
131 Nishi T, Babazono A, Maeda T, Imatoh T, Une H. Evaluation of the fatty liver index as a predictor for the development of diabetes among insurance beneficiaries with prediabetes. J Diabetes Investig 2015;6:309-16. [PMID: 25969716 DOI: 10.1111/jdi.12290] [Cited by in Crossref: 15] [Cited by in F6Publishing: 17] [Article Influence: 1.9] [Reference Citation Analysis]
132 Sénéchal M, Slaght J, Bharti N, Bouchard DR. Independent and combined effect of diet and exercise in adults with prediabetes. Diabetes Metab Syndr Obes 2014;7:521-9. [PMID: 25382981 DOI: 10.2147/DMSO.S62367] [Cited by in Crossref: 3] [Cited by in F6Publishing: 7] [Article Influence: 0.4] [Reference Citation Analysis]
133 Diabetes Prevention Program Research Group. HbA1c as a predictor of diabetes and as an outcome in the diabetes prevention program: a randomized clinical trial. Diabetes Care 2015;38:51-8. [PMID: 25336746 DOI: 10.2337/dc14-0886] [Cited by in Crossref: 71] [Cited by in F6Publishing: 78] [Article Influence: 8.9] [Reference Citation Analysis]
134 Lind M, Tuomilehto J, Uusitupa M, Nerman O, Eriksson J, Ilanne-Parikka P, Keinänen-Kiukaanniemi S, Peltonen M, Pivodic A, Lindström J. The association between HbA1c, fasting glucose, 1-hour glucose and 2-hour glucose during an oral glucose tolerance test and cardiovascular disease in individuals with elevated risk for diabetes. PLoS One. 2014;9:e109506. [PMID: 25285769 DOI: 10.1371/journal.pone.0109506] [Cited by in Crossref: 33] [Cited by in F6Publishing: 37] [Article Influence: 4.1] [Reference Citation Analysis]
135 Glauber H, Karnieli E. Preventing type 2 diabetes mellitus: a call for personalized intervention. Perm J 2013;17:74-9. [PMID: 24355893 DOI: 10.7812/TPP/12-143] [Cited by in Crossref: 14] [Cited by in F6Publishing: 18] [Article Influence: 1.8] [Reference Citation Analysis]
136 Jaacks LM, Ma Y, Davis N, Delahanty LM, Mayer-Davis EJ, Franks PW, Brown-Friday J, Isonaga M, Kriska AM, Venditti EM. Long-term changes in dietary and food intake behaviour in the Diabetes Prevention Program Outcomes Study. Diabet Med. 2014;31:1631-1642. [PMID: 24824893 DOI: 10.1111/dme.12500] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 2.5] [Reference Citation Analysis]
137 Li G, Zhang P, Wang J, An Y, Gong Q, Gregg EW, Yang W, Zhang B, Shuai Y, Hong J, Engelgau MM, Li H, Roglic G, Hu Y, Bennett PH. Cardiovascular mortality, all-cause mortality, and diabetes incidence after lifestyle intervention for people with impaired glucose tolerance in the Da Qing Diabetes Prevention Study: a 23-year follow-up study. The Lancet Diabetes & Endocrinology 2014;2:474-80. [DOI: 10.1016/s2213-8587(14)70057-9] [Cited by in Crossref: 418] [Cited by in F6Publishing: 439] [Article Influence: 52.3] [Reference Citation Analysis]
138 Sakane N, Sato J, Tsushita K, Tsujii S, Kotani K, Tominaga M, Kawazu S, Sato Y, Usui T, Kamae I, Yoshida T, Kiyohara Y, Sato S, Tsuzaki K, Takahashi K, Kuzuya H; Japan Diabetes Prevention Program (JDPP) Research Group. Effect of baseline HbA1c level on the development of diabetes by lifestyle intervention in primary healthcare settings: insights from subanalysis of the Japan Diabetes Prevention Program. BMJ Open Diabetes Res Care 2014;2:e000003. [PMID: 25452854 DOI: 10.1136/bmjdrc-2013-000003] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 1.3] [Reference Citation Analysis]
139 Hartmann-Boyce J, Johns DJ, Jebb SA, Aveyard P; Behavioural Weight Management Review Group. Effect of behavioural techniques and delivery mode on effectiveness of weight management: systematic review, meta-analysis and meta-regression. Obes Rev 2014;15:598-609. [PMID: 24636238 DOI: 10.1111/obr.12165] [Cited by in Crossref: 142] [Cited by in F6Publishing: 146] [Article Influence: 17.8] [Reference Citation Analysis]
140 Merlotti C, Morabito A, Pontiroli AE. Prevention of type 2 diabetes; a systematic review and meta-analysis of different intervention strategies. Diabetes Obes Metab. 2014;16:719-727. [PMID: 24476122 DOI: 10.1111/dom.12270] [Cited by in Crossref: 99] [Cited by in F6Publishing: 108] [Article Influence: 12.4] [Reference Citation Analysis]
141 Mastellos N, Gunn LH, Felix LM, Car J, Majeed A. Transtheoretical model stages of change for dietary and physical exercise modification in weight loss management for overweight and obese adults. Cochrane Database Syst Rev 2014;:CD008066. [PMID: 24500864 DOI: 10.1002/14651858.CD008066.pub3] [Cited by in Crossref: 53] [Cited by in F6Publishing: 78] [Article Influence: 6.6] [Reference Citation Analysis]
142 Knowler WC, Ackermann RT. Preventing diabetes in American Indian communities. Diabetes Care 2013;36:1820-2. [PMID: 23801794 DOI: 10.2337/dc12-2635] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
143 Rydén L, Grant PJ, Anker SD, Berne C, Cosentino F, Danchin N, Deaton C, Escaned J, Hammes H, Huikuri H, Marre M, Marx N, Mellbin L, Ostergren J, Patrono C, Seferovic P, Sousa Uva M, Taskinen M, Tendera M, Tuomilehto J, Valensi P, Luis Zamorano J, Luis Zamorano J, Achenbach S, Baumgartner H, Bax JJ, Bueno H, Dean V, Deaton C, Erol Ç, Fagard R, Ferrari R, Hasdai D, Hoes AW, Kirchhof P, Knuuti J, Kolh P, Lancellotti P, Linhart A, Nihoyannopoulos P, Piepoli MF, Ponikowski P, Anton Sirnes P, Luis Tamargo J, Tendera M, Torbicki A, Wijns W, Windecker S, De Backer G, Anton Sirnes P, Alegria Ezquerra E, Avogaro A, Badimon L, Baranova E, Baumgartner H, Betteridge J, Ceriello A, Fagard R, Funck-brentano C, Gulba DC, Hasdai D, Hoes AW, Kjekshus JK, Knuuti J, Kolh P, Lev E, Mueller C, Neyses L, Nilsson PM, Perk J, Ponikowski P, Reiner Ž, Sattar N, Schächinger V, Scheen A, Schirmer H, Strömberg A, Sudzhaeva S, Luis Tamargo J, Viigimaa M, Vlachopoulos C, Xuereb RG; Grupo de Trabajo de la Sociedad Europea de Cardiología sobre diagnóstico y tratamiento de la cardiopatía isquémica estable, Grupo de Trabajo de la Sociedad Europea de Cardiología sobre diagnóstico y tratamiento de la cardiopatía isquémica estable, Grupo de Trabajo de la Sociedad Europea de Cardiología sobre diagnóstico y tratamiento de la cardiopatía isquémica estable. Guía de práctica clínica de la ESC sobre diabetes, prediabetes y enfermedad cardiovascular, en colaboración con la European Association for the Study of Diabetes. Revista Española de Cardiología 2014;67:136.e1-136.e56. [DOI: 10.1016/j.recesp.2013.10.015] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
144 Kim SH, Liu A, Ariel D, Abbasi F, Lamendola C, Grove K, Tomasso V, Reaven G. Pancreatic beta cell function following liraglutide-augmented weight loss in individuals with prediabetes: analysis of a randomised, placebo-controlled study. Diabetologia. 2014;57:455-462. [PMID: 24326527 DOI: 10.1007/s00125-013-3134-3] [Cited by in Crossref: 27] [Cited by in F6Publishing: 28] [Article Influence: 3.0] [Reference Citation Analysis]
145 Hussein Z, Hamdy O, Chin Chia Y, Lin Lim S, Kumari Natkunam S, Hussain H, Yeong Tan M, Sulaiman R, Nisak B, Chee WS, Marchetti A, Hegazi RA, Mechanick JI. Transcultural diabetes nutrition algorithm: a malaysian application. Int J Endocrinol 2013;2013:679396. [PMID: 24385984 DOI: 10.1155/2013/679396] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 1.4] [Reference Citation Analysis]
146 Chakkera HA, Weil EJ, Pham PT, Pomeroy J, Knowler WC. Can new-onset diabetes after kidney transplant be prevented? Diabetes Care. 2013;36:1406-1412. [PMID: 23613600 DOI: 10.2337/dc12-2067] [Cited by in Crossref: 51] [Cited by in F6Publishing: 56] [Article Influence: 5.7] [Reference Citation Analysis]
147 Lanas F, Serón P, Lanas A. Coronary Heart Disease and Risk Factors in Latin America. gh 2020;8:341. [DOI: 10.1016/j.gheart.2013.11.005] [Cited by in Crossref: 20] [Cited by in F6Publishing: 23] [Article Influence: 2.2] [Reference Citation Analysis]
148 . Réduction du risque de diabète. Canadian Journal of Diabetes 2013;37:S607. [DOI: 10.1016/j.jcjd.2013.07.002] [Reference Citation Analysis]
149 Herzig KH, Ahola R, Leppäluoto J, Jokelainen J, Jämsä T, Keinänen-Kiukaanniemi S. Light physical activity determined by a motion sensor decreases insulin resistance, improves lipid homeostasis and reduces visceral fat in high-risk subjects: PreDiabEx study RCT. Int J Obes (Lond) 2014;38:1089-96. [PMID: 24285336 DOI: 10.1038/ijo.2013.224] [Cited by in Crossref: 48] [Cited by in F6Publishing: 49] [Article Influence: 5.3] [Reference Citation Analysis]
150 Kim JY, Lee KH, Kim SH, Kim KH, Kim JH, Han JS, Bang SS, Shin JH, Kim SH, Hwang EJ, Bae WK. Needs analysis and development of a tailored mobile message program linked with electronic health records for weight reduction. International Journal of Medical Informatics 2013;82:1123-32. [DOI: 10.1016/j.ijmedinf.2013.08.004] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.0] [Reference Citation Analysis]
151 Perreault L, Færch K. Approaching pre-diabetes. J Diabetes Complications 2014;28:226-33. [PMID: 24342268 DOI: 10.1016/j.jdiacomp.2013.10.008] [Cited by in Crossref: 38] [Cited by in F6Publishing: 43] [Article Influence: 4.2] [Reference Citation Analysis]
152 Ransom T, Goldenberg R, Mikalachki A, Prebtani AP, Punthakee Z. Réduction du risque de diabète. Canadian Journal of Diabetes 2013;37:S377-S380. [DOI: 10.1016/j.jcjd.2013.07.033] [Reference Citation Analysis]
153 Gregg EW, Geiss L, Zhang P, Zhuo X, Williamson DF, Albright AL. Implications of risk stratification for diabetes prevention: the case of hemoglobin A1c. Am J Prev Med 2013;44:S375-80. [PMID: 23498302 DOI: 10.1016/j.amepre.2012.12.012] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 1.1] [Reference Citation Analysis]
154 Goto A, Goto M, Noda M, Tsugane S. Incidence of type 2 diabetes in Japan: a systematic review and meta-analysis. PLoS One 2013;8:e74699. [PMID: 24040326 DOI: 10.1371/journal.pone.0074699] [Cited by in Crossref: 30] [Cited by in F6Publishing: 32] [Article Influence: 3.3] [Reference Citation Analysis]
155 Khavandi K, Amer H, Ibrahim B, Brownrigg J. Strategies for preventing type 2 diabetes: an update for clinicians. Ther Adv Chronic Dis. 2013;4:242-261. [PMID: 23997928 DOI: 10.1177/2040622313494986] [Cited by in Crossref: 31] [Cited by in F6Publishing: 27] [Article Influence: 3.4] [Reference Citation Analysis]
156 Kim SH, Abbasi F, Lamendola C, Liu A, Ariel D, Schaaf P, Grove K, Tomasso V, Ochoa H, Liu YV. Benefits of liraglutide treatment in overweight and obese older individuals with prediabetes. Diabetes Care. 2013;36:3276-3282. [PMID: 23835684 DOI: 10.2337/dc13-0354] [Cited by in Crossref: 59] [Cited by in F6Publishing: 65] [Article Influence: 6.6] [Reference Citation Analysis]
157 Dankner R, Bergman M, Danoff A, Qureshi S, Whitford I, Kaviani N, Dynkevich Y, Roth J. The metabolic deterioration that antedates diabetes: personal trajectories of HbA(1c) and fasting glucose as early indicators and possible triggers for intervention. Diabetes Metab Res Rev. 2013;29:1-7. [PMID: 23175191 DOI: 10.1002/dmrr.2373] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 0.9] [Reference Citation Analysis]
158 Choi HC, Kim SJ, Son KY, Oh BJ, Cho BL. Metabolic effects of aloe vera gel complex in obese prediabetes and early non-treated diabetic patients: randomized controlled trial. Nutrition. 2013;29:1110-1114. [PMID: 23735317 DOI: 10.1016/j.nut.2013.02.015] [Cited by in Crossref: 50] [Cited by in F6Publishing: 51] [Article Influence: 5.6] [Reference Citation Analysis]
159 Reducing the Risk of Developing Diabetes. Canadian Journal of Diabetes 2013;37:S298. [DOI: 10.1016/j.jcjd.2013.02.004] [Reference Citation Analysis]
160 Nakagaki M, Mclellan K. Diabetes Tipo 2 e Estilo de Vida: O Papel do Exercício Físico na Atenção Primária e na Secundária. Saúde em Revista 2013;13:67-75. [DOI: 10.15600/2238-1244/sr.v13n33p67-75] [Reference Citation Analysis]
161 Ransom T, Goldenberg R, Mikalachki A, Prebtani AP, Punthakee Z; Canadian Diabetes Association Clinical Practice Guidelines Expert Committee. Reducing the risk of developing diabetes. Can J Diabetes 2013;37 Suppl 1:S16-9. [PMID: 24070941 DOI: 10.1016/j.jcjd.2013.01.013] [Cited by in Crossref: 7] [Cited by in F6Publishing: 10] [Article Influence: 0.8] [Reference Citation Analysis]
162 da Silva Alves E, de Aquino Lemos V, Ruiz da Silva F, Lira FS, Dos Santos RV, Rosa JP, Caperuto E, Tufik S, de Mello MT. Low-grade inflammation and spinal cord injury: exercise as therapy? Mediators Inflamm 2013;2013:971841. [PMID: 23533315 DOI: 10.1155/2013/971841] [Cited by in Crossref: 22] [Cited by in F6Publishing: 24] [Article Influence: 2.4] [Reference Citation Analysis]
163 Penn L, White M, Lindström J, den Boer AT, Blaak E, Eriksson JG, Feskens E, Ilanne-Parikka P, Keinänen-Kiukaanniemi SM, Walker M, Mathers JC, Uusitupa M, Tuomilehto J. Importance of weight loss maintenance and risk prediction in the prevention of type 2 diabetes: analysis of European Diabetes Prevention Study RCT. PLoS One 2013;8:e57143. [PMID: 23451166 DOI: 10.1371/journal.pone.0057143] [Cited by in Crossref: 81] [Cited by in F6Publishing: 85] [Article Influence: 9.0] [Reference Citation Analysis]
164 Færch K, Witte DR, Tabák AG, Perreault L, Herder C, Brunner EJ, Kivimäki M, Vistisen D. Trajectories of cardiometabolic risk factors before diagnosis of three subtypes of type 2 diabetes: a post-hoc analysis of the longitudinal Whitehall II cohort study. Lancet Diabetes Endocrinol 2013;1:43-51. [PMID: 24622266 DOI: 10.1016/S2213-8587(13)70008-1] [Cited by in Crossref: 70] [Cited by in F6Publishing: 72] [Article Influence: 7.8] [Reference Citation Analysis]
165 Sakane N, Kotani K, Takahashi K, Sano Y, Tsuzaki K, Okazaki K, Sato J, Suzuki S, Morita S, Izumi K, Kato M, Ishizuka N, Noda M, Kuzuya H. Japan Diabetes Outcome Intervention Trial-1 (J-DOIT1), a nationwide cluster randomized trial of type 2 diabetes prevention by telephone-delivered lifestyle support for high-risk subjects detected at health checkups: rationale, design, and recruitment. BMC Public Health 2013;13:81. [PMID: 23356246 DOI: 10.1186/1471-2458-13-81] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
166 Ilanne-parikka P, Tuomilehto J. Lifestyle Intervention: Prevention of Complications to the Metabolic Syndrome. The Metabolic Syndrome 2013. [DOI: 10.1007/978-3-7091-1331-8_6] [Reference Citation Analysis]
167 Nolan JJ, Færch K. Estimating insulin sensitivity and beta cell function: perspectives from the modern pandemics of obesity and type 2 diabetes. Diabetologia 2012;55:2863-7. [PMID: 22911384 DOI: 10.1007/s00125-012-2684-0] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 1.8] [Reference Citation Analysis]
168 de Lemos ET, Oliveira J, Pinheiro JP, Reis F. Regular physical exercise as a strategy to improve antioxidant and anti-inflammatory status: benefits in type 2 diabetes mellitus. Oxid Med Cell Longev 2012;2012:741545. [PMID: 22928086 DOI: 10.1155/2012/741545] [Cited by in Crossref: 34] [Cited by in F6Publishing: 48] [Article Influence: 3.4] [Reference Citation Analysis]
169 Hsu WC, Boyko EJ, Fujimoto WY, Kanaya A, Karmally W, Karter A, King GL, Look M, Maskarinec G, Misra R. Pathophysiologic differences among Asians, native Hawaiians, and other Pacific Islanders and treatment implications. Diabetes Care. 2012;35:1189-1198. [PMID: 22517940 DOI: 10.2337/dc12-0212] [Cited by in Crossref: 47] [Cited by in F6Publishing: 53] [Article Influence: 4.7] [Reference Citation Analysis]
170 Perreault L, Pan Q, Mather KJ, Watson KE, Hamman RF, Kahn SE; Diabetes Prevention Program Research Group. Effect of regression from prediabetes to normal glucose regulation on long-term reduction in diabetes risk: results from the Diabetes Prevention Program Outcomes Study. Lancet 2012;379:2243-51. [PMID: 22683134 DOI: 10.1016/S0140-6736(12)60525-X] [Cited by in Crossref: 288] [Cited by in F6Publishing: 313] [Article Influence: 28.8] [Reference Citation Analysis]
171 Tabák AG, Herder C, Rathmann W, Brunner EJ, Kivimäki M. Prediabetes: a high-risk state for diabetes development. Lancet. 2012;379:2279-2290. [PMID: 22683128 DOI: 10.1016/s0140-6736(12)60283-9] [Cited by in Crossref: 1388] [Cited by in F6Publishing: 1478] [Article Influence: 138.8] [Reference Citation Analysis]
172 Rice GE, Illanes SE, Mitchell MD. Gestational diabetes mellitus: a positive predictor of type 2 diabetes? Int J Endocrinol 2012;2012:721653. [PMID: 22675354 DOI: 10.1155/2012/721653] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 0.5] [Reference Citation Analysis]
173 Dankner R, Roth J. Predicting Diabetes. In: Leroith D, editor. Prevention of Type 2 Diabetes. New York: Springer; 2012. pp. 81-102. [DOI: 10.1007/978-1-4614-3314-9_6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
174 Lam DW, Leroith D. The worldwide diabetes epidemic: . Current Opinion in Endocrinology & Diabetes and Obesity 2012;19:93-6. [DOI: 10.1097/med.0b013e328350583a] [Cited by in Crossref: 216] [Cited by in F6Publishing: 230] [Article Influence: 21.6] [Reference Citation Analysis]
175 Fujimoto WY, Boyko EJ, Hayashi T, Kahn SE, Leonetti DL, McNeely MJ, Shuman WP. Risk Factors for Type 2 Diabetes: Lessons Learned from Japanese Americans in Seattle. J Diabetes Investig 2012;3:212-24. [PMID: 22798980 DOI: 10.1111/j.2040-1124.2012.00195.x] [Cited by in Crossref: 26] [Cited by in F6Publishing: 29] [Article Influence: 2.6] [Reference Citation Analysis]
176 Esparza EM, Arch RH. TRAF4 functions as an intermediate of GITR-induced NF-kappaB activation. Cell Mol Life Sci. 2004;61:3087-3092. [PMID: 15583869 DOI: 10.1007/s00018-004-4417-0] [Cited by in Crossref: 44] [Cited by in F6Publishing: 48] [Article Influence: 2.6] [Reference Citation Analysis]